RxDoctor Payments Data

Srinivas Devarakonda, MD

Hematology · Columbus, OHNPI 1154595049

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,090 of the $10,961 with a category attached, or 82.9%. Janssen Research & Development, LLC accounts for 67.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2022 at $5,068 and has fallen 98.1% since, to $95 in 2025. That places this record below the midpoint for hematology clinicians in OH, where the typical reported total is $9,915.

$10,961in general payments, 2019–2025

Across 30 payments — averaging $365.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$7K
  • Janssen Scientific Affairs, LLC$2K
  • Adaptive Biotechnologies Corporation$1K
  • Johnson & Johnson$132
  • Amgen$84
  • Regeneron Healthcare Solutions, Inc.$74
  • plus $133 from 3 others
$475,596in research payments, 2019–2025

Across 83 payments — averaging $5730.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$147K
  • Janssen Research & Development, LLC$132K
  • Takeda Pharmaceuticals U.S.A., Inc.$97K
  • GSK$46K
  • AbbVie$35K
  • E.r. Squibb & Sons, L.L.C.$10K
  • plus $8K from 1 others

What the payments were for

  • Consulting fees$9,09083%
  • Travel & lodging$6876%
  • Food & beverage$1,18411%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,961 in reported general payments places this provider in the 50th percentile of 84 hematology providers in Ohio.

See all hematology providers in Ohio

Medicare billing

Part B allowed, 2024
$57,412
Medicare patients
203
Services billed
443

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →